Intellectual property rights trump the right to health: Canada’s Access to Medicines Regime and TRIPs flexibilities in the context of Bolivia’s quest for vaccines

The failure of the Canadian pharmaceutical company Biolyse Pharma to obtain authorization under Canada’s Access to Medicines Regime (CAMR) to produce 15 million badly needed doses of a generic copy of a vaccine needed by a developing country is the occasion for a reflection on the right to health an...

Full description

Saved in:  
Bibliographic Details
Main Author: Crombie, James (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Fernleihe:Fernleihe für die Fachinformationsdienste
Published: Routledge, Taylor & Francis Group 2021
In: Journal of global ethics
Year: 2021, Volume: 17, Issue: 3, Pages: 353-366
Further subjects:B compulsory licensing
B covid-19 vaccines
B delinkage
B TRIPS
B Bolivia
B right to health
Online Access: Volltext (kostenfrei)

MARC

LEADER 00000caa a22000002 4500
001 1793973571
003 DE-627
005 20230427030949.0
007 cr uuu---uuuuu
008 220226s2021 xx |||||o 00| ||eng c
024 7 |a 10.1080/17449626.2021.1993452  |2 doi 
035 |a (DE-627)1793973571 
035 |a (DE-599)KXP1793973571 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Crombie, James  |e VerfasserIn  |4 aut 
245 1 0 |a Intellectual property rights trump the right to health: Canada’s Access to Medicines Regime and TRIPs flexibilities in the context of Bolivia’s quest for vaccines 
264 1 |c 2021 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a The failure of the Canadian pharmaceutical company Biolyse Pharma to obtain authorization under Canada’s Access to Medicines Regime (CAMR) to produce 15 million badly needed doses of a generic copy of a vaccine needed by a developing country is the occasion for a reflection on the right to health and the compatibility of this right with the dominant system of intellectual property rights (IPR) under the 1994 Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), the Doha Declaration and subsequent decisions. Global health justice and intellectual property rights are difficult to reconcile because patent-supported pricing limits equitable access to medicines and, in addition, produces distortions in the allocation of resources in health research. A ‘delinkage’ of production and development costs is therefore called for. In spite of this, governments of countries with an important pharmaceutical sector are often hesitant to agree to sharing of information and technologies. The ‘flexibilities’ (mainly ‘waivers’ and ‘compulsory licenses’) provided for under the TRIPS system are not applied in a serious and consistent way in order to allow developing countries to deal with health crises, as is illustrated by extreme variation in rates of vaccination between the developed and the less developed world. 
650 4 |a compulsory licensing 
650 4 |a covid-19 vaccines 
650 4 |a Bolivia 
650 4 |a delinkage 
650 4 |a TRIPS 
650 4 |a right to health 
773 0 8 |i Enthalten in  |t Journal of global ethics  |d London : Routledge, Taylor & Francis Group, 2005  |g 17(2021), 3, Seite 353-366  |h Online-Ressource  |w (DE-627)506719197  |w (DE-600)2219472-1  |w (DE-576)378913263  |x 1744-9634  |7 nnns 
773 1 8 |g volume:17  |g year:2021  |g number:3  |g pages:353-366 
856 |u https://www.tandfonline.com/doi/pdf/10.1080/17449626.2021.1993452?needAccess=true  |x unpaywall  |z Vermutlich kostenfreier Zugang  |h publisher [open (via crossref license)] 
856 4 0 |u https://doi.org/10.1080/17449626.2021.1993452  |x Resolving-System  |z kostenfrei  |3 Volltext 
935 |a mteo 
936 u w |d 17  |j 2021  |e 3  |h 353-366 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4073906836 
LOK |0 003 DE-627 
LOK |0 004 1793973571 
LOK |0 005 20220226052600 
LOK |0 008 220226||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-Tue135)IxTheo#2022-02-25#55F0CB6FBBC89513F7C012C0A8DB926C7C18FBF2 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 935   |a ixzs  |a zota 
OAS |a 1 
ORI |a SA-MARC-ixtheoa001.raw